APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 53 filers reported holding APTOSE BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $209 | -15.4% | 74,666 | +40.0% | 0.05% | -26.8% |
| Q2 2023 | $247 | -51.9% | 53,332 | -93.3% | 0.07% | -56.2% |
| Q1 2023 | $513 | +10.6% | 800,000 | 0.0% | 0.16% | +5.9% |
| Q4 2022 | $464 | -99.9% | 800,000 | +12.7% | 0.15% | -1.9% |
| Q3 2022 | $422,000 | +45.5% | 710,000 | +81.6% | 0.16% | +35.7% |
| Q2 2022 | $290,000 | +6.6% | 390,894 | +95.4% | 0.12% | +7.5% |
| Q1 2022 | $272,000 | – | 200,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 565,000 | $768,000 | 0.80% |
| SANDERS MORRIS HARRIS LLC | 2,342,694 | $3,186,000 | 0.62% |
| Nantahala Capital Management | 7,322,189 | $9,958,000 | 0.44% |
| DRW Securities, LLC | 8,892,437 | $12,094,000 | 0.33% |
| PRECEPT MANAGEMENT LLC | 227,000 | $309,000 | 0.33% |
| Voss Capital, LLC | 550,000 | $748,000 | 0.24% |
| CARLSON CAPITAL L P | 1,564,700 | $2,128,000 | 0.15% |
| Annandale Capital, LLC | 200,000 | $272,000 | 0.11% |
| Sigma Planning Corp | 791,274 | $1,076,000 | 0.03% |
| WealthShield Partners, LLC | 104,920 | $143,000 | 0.02% |